Health Catalyst Inc

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Health Catalyst Inc reports solid 2022 performance and eyes margin growth opportunities

Health Catalyst Inc delivered strong financial performance in 2022, with revenue growth, improved EBITDA, and a positive outlook for 2023. The company's focus on client relationships, tech-enabled services, and margin improvement positions it well for future success. Challenges such as long sales cycles and migration costs are being managed strategically to drive growth.

Health Catalyst beats Q1 revenue targets, eyes tech-enabled growth

Health Catalyst's Q1 2023 performance showed revenue growth and operational efficiency, with a focus on recurring revenue and client relationships.
While facing challenges in the health system market and revenue lumpiness, the company aims for growth through tech-enabled services and cost-saving strategies.
Opportunities lie in expanding into the ambulatory space, offering modular solutions, and investing in tech capabilities for long-term differentiation and client value.
Overall, Health Catalyst remains cautious about expansion, prioritizing being a differentiated long-term partner to effectively deliver for clients.

Health Catalyst beats Q2 expectations, eyes growth in managed services

Health Catalyst's Q2 performance exceeded expectations, with raised guidance for 2023.
Focus on tech-enabled managed services and long-term client relationships driving growth.
Challenges include longer sales cycles and improving gross margins in contracts.
Opportunities lie in margin improvement, summit impact on bookings, and clinic operations.

Health Catalyst Inc beats Q3 revenue, eyes strong Q4 bookings

Health Catalyst Inc (HCAT) exceeded revenue expectations in Q3 2023 and raised full-year guidance, with strong bookings performance.
The company is focusing on optimizing costs, anticipating a large bookings quarter in Q4 2023.
Recognized for team member engagement and client success stories, with a healthy cash position.
Anticipating growth opportunities in professional services and tech-enabled managed services contracts.

Health Catalyst exceeds Q4 revenue targets, eyes sustainable growth

Health Catalyst Inc's Q4 2023 earnings call highlighted strong financial performance, exceeding revenue and EBITDA guidance, with a focus on client growth and retention.
The company's strategic objectives include migrating clients to a next-gen data platform, balancing growth between tech and services, and driving profitability through operational efficiency.
While facing challenges in client migration and balancing growth, Health Catalyst is well-positioned to capitalize on opportunities like the next-gen platform rollout and cross-selling efforts.
Overall, Health Catalyst's performance, strengths, challenges, and opportunities indicate a strategic focus on sustainable growth, profitability, and enhancing client relationships.

Health Catalyst surpasses Q1 expectations, eyes tech-driven growth

Health Catalyst demonstrated financial resilience and client-centric approach in Q1 2024.
Strategic focus on technology and services to drive growth and avoid limitations.
Opportunities in adjacent markets and client engagement for sustained expansion.
Challenges include managing R&D expenses and potential disruptions from external factors.

Health Catalyst surpasses Q2 revenue targets, eyes growth opportunities

Health Catalyst's Q2 2024 performance exceeded expectations, showcasing strong revenue and margin metrics.
The company's strategic strengths lie in client recognition, acquisitions, platform migration progress, and growth outlook.
Challenges include client retention, revenue growth, margin optimization, and disciplined capital deployment.
Opportunities for Health Catalyst include leveraging financial strength, cross-selling, technology focus, and Ignite platform benefits.

Health Catalyst exceeds Q3 expectations, eyes growth through strategic initiatives

Health Catalyst Inc's Q3 2024 earnings call showcased strong financial performance, positive outlook, and strategic initiatives for growth.
The company's focus on client relationships, market demand, and acquisitions positions it well for future success and industry leadership.
While challenges like margin expansion and competition exist, Health Catalyst Inc's strengths and opportunities indicate a promising trajectory.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

The consensus price target hints at a 61.5% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Does Health Catalyst (HCAT) Have the Potential to Rally 61% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 113% in Health Catalyst (HCAT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Can Health Catalyst (HCAT) Climb 113% to Reach the Level Wall Street Analysts Expect?

The company continued its upward trend in revenue growth.

Why Shares of Health Catalyst Popped 23.34% on Wednesday

Health Catalyst, Inc. (NASDAQ:HCAT ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Adam Brown - Senior Vice President-Finance and Investor Relations Daniel Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Richard Close - Canaccord Genuity Daniel Grosslight - Citi David Larsen - BTIG Cindy Motz - Goldman Sachs Jack Wallace - Guggenheim Securities Operator Welcome to the Health Catalyst Third Quarter 2022 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode and the floor will be opened for your questions following the presentation.

Health Catalyst, Inc. (HCAT) Q3 2022 Earnings Call Transcript

Health Catalyst (HCAT) delivered earnings and revenue surprises of 35% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (HCAT) Reports Q3 Loss, Tops Revenue Estimates

SALT LAKE CITY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2022.

Health Catalyst Reports Third Quarter 2022 Results

SALT LAKE CITY , Nov. 2, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced KPI Ninja by Health Catalyst™–the most comprehensive end-to-end solution to help Health Information Exchanges (HIEs) smoothly transition from being transactional data intermediaries to population health enablers–has earned National Committee for Quality Assurance (NCQA) Certification for HEDIS® Measures (MY 2022) for the third consecutive year. This certification for its Health Plan Measures and Allowable Adjustment Measures validates that the HEDIS measure logic KPI Ninja uses to calculate measures results or select eligible patients' administrative or clinical data sources will produce accurate results.

KPI Ninja Receives NCQA Measure Certification™ for HEDIS® Measurement Year 2022, Solidifying Its Comprehensive End-to-End Solution for Health Information Exchanges

SALT LAKE CITY , Oct. 31, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has been named a 2022 Top Workplace in Utah  by the Salt Lake Tribune–the ninth year in a row Health Catalyst has received this distinction. "We're greatly honored by this regional recognition," said Linda Llewelyn, Chief People Officer at Health Catalyst.

Health Catalyst Named a Top Workplace in Utah for the Ninth Consecutive Year

SALT LAKE CITY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2022 operating results on Tuesday, November 8, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Third Quarter 2022 Operating Results and Host Conference Call on Tuesday, November 8, 2022

Health Catalyst has been on my "Bio Boom" watch list for a couple of years, but the valuation has stopped me from starting a position. The market-wide sell-off has brought the share price down to an acceptable valuation to allow me to finally find a spot for HCAT in my Compounding Healthcare “Bio Boom” Portfolio.

Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate

SALT LAKE CITY , Sept. 14, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the winners of its fourth annual Catalyst Awards.

Health Catalyst Reveals Catalyst Awards Winners Recognizing World-Class Healthcare Improvements

Announces Appointments of Kevin Freeman as Chief Growth Officer, Tarah Neujahr Bryan as Chief Marketing Officer, and Dave Ross as Chief Technology Officer SALT LAKE CITY , Sept. 7, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced three new leadership assignments in support of its strategic focus areas moving forward.

Health Catalyst Announces New Leadership Assignments in Support of Strategic Focus Areas

SALT LAKE CITY , Aug. 8, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," NASDAQ: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the addition of Chief Medical Officer Dr. Melissa Welch and Chief Population Health Officer and Senior Vice President Dr. Edward Sheen to the executive leadership team.  Dr. Welch will be the physician voice supporting new and current client growth–driving data-informed healthcare improvements across all areas of the business.

Health Catalyst Welcomes Chief Medical Officer Dr. Melissa Welch and Chief Population Health Officer and Senior Vice President Dr. Edward Sheen to Leadership Team

Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Adam Brown – Senior Vice President-Finance and Investor Relations Dan Burton – Chief Executive Officer Bryan Hunt – Chief Financial Officer Conference Call Participants Anne Samuel – J.P. Morgan Jared Haase – William Blair Elizabeth Anderson – Evercore Stephanie Davis – SVB Securities John Ransom – Raymond James Jessica Tassan – Piper Sandler Richard Close – Canaccord Genuity Daniel Grosslight – Citi Rohan Chandrasekhar – Guggenheim Partners Operator Good day, ladies and gentlemen, and thank you for standing by.

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2022 Results - Earnings Call Transcript

Health Catalyst (HCAT) delivered earnings and revenue surprises of 72.73% and 1.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (HCAT) Reports Q2 Loss, Tops Revenue Estimates

SALT LAKE CITY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that its board of directors approved a share repurchase program with authorization to purchase up to $40 million of its Common Stock, effective immediately.

Health Catalyst Announces $40 Million Share Repurchase Program

SALT LAKE CITY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2022.

Health Catalyst Reports Second Quarter 2022 Results

Bloomin' Brands

Cerence

FTC Solar

Dave & Buster's

Six Flags

Traeger

When equities are under pressure, it is particularly important for investors to find stocks that are trading at a discount to their intrinsic value. This can be particularly difficult if you're interested in finding small-cap growth stocks trading at a discount.

7 Small-Cap Growth Stocks Trading at a Huge Discount Right Now

Axcelis Technologies

Axsome Therapeutics

Global Blood Therapeutics

GoPro

Skillz

Veru

Small-cap growth stocks with 1,000% upside potential is our topic for today. They are usually young companies with a market capitalization (cap) between $300 million and $2 billion.

7 Small-Cap Growth Stocks With 1,000% Upside Potential

Health system leverages innovative data and analytics technology to further drive improvements in quality and patient safety in communities nationwide SALT LAKE CITY , July 27, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year partnership with LifePoint Health, a diversified healthcare delivery network that operates 63 community hospital campuses, more than 30 rehabilitation and behavioral health hospitals, and 170 additional sites of care from coast to coast. The partnership will leverage Health Catalyst's robust technology and solutions to help reduce variation in clinical outcomes for patients, improve the overall quality of care, and further advance LifePoint's data and analytics capabilities to support its award-winning National Quality Program.

LifePoint Health Partners with Health Catalyst to Advance Patient Care

SALT LAKE CITY , July 26, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expansive, multi-year strategic partnership with Akron Children's Hospital (Akron Children's), a top-ranking pediatric health system in northeast Ohio with two hospitals and 54 urgent, primary, and specialty care locations. "Health Catalyst will become a fundamental component of our robust analytics platform, which will bring multiple sources of data to assist in data-driven decision making," said Harun Rashid, Chief Information Officer for Akron Children's.

Health Catalyst and Akron Children's Hospital Team Up to Advance Population Health Efforts

SALT LAKE CITY, July 21, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2022 operating results on Thursday, August 4, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022

Twistle by Health Catalyst™ patient engagement technology to meet the unique needs of MemorialCare's pediatric cardiology patients and caregivers SALT LAKE CITY , July 21, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a partnership with MemorialCare Miller Children's & Women's Hospital Long Beach ("MemorialCare"), a leading, innovative nonprofit health system in Orange and Los Angeles Counties. MemorialCare stands for innovation in patient care and its children's hospital is the only hospital in the region to offer Twistle by Health Catalyst's ("Twistle") communication capability to its pediatric cardiology patients.

Health Catalyst, MemorialCare Team Up to Improve Care Outcomes with Innovative Patient Engagement Technology

SALT LAKE CITY , July 12, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Carle Health (Carle) has selected Health Catalyst PowerCosting™ to power the health system's financial transformation. "We are dedicated to creating the highest quality care experience possible for patients and members in every way," Dennis Hesch, CPA, Carle Health chief financial officer and Health Alliance chief executive officer.

Health Catalyst, Carle Health Strengthen Partnership in Support of the Health System's Financial Transformation Goals

300 Customer Case Studies Document Health Catalyst's Efforts to Power Clinical, Operational, and Financial Improvements SALT LAKE CITY , June 23, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has documented over 5.4 million lives positively impacted by improvement initiatives, $1.5 billion in validated measurable improvements, and 300 case studies – a result of its data and analytics technology, professional services, and deep customer relationships. The total annual cost of healthcare waste, which ranges between $760 billion and $935 billion according to a Journal of the American Medical Association (JAMA) report, continues to plague the healthcare industry.

News for Health Catalyst Inc Stock (HCAT)